540222:BOM
Laurus Labs Ltd
2 059,00 ₹
arrow_upward
+1,93%(+39,00) 1D
16 қаз., 15:59:49 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 540222...
Open
2 027,35 ₹
High
2 086,00 ₹
Low
2 027,35 ₹
Mkt. cap
1,11 трлн
Avg. vol.
84,29 мың
Volume
103,13 м.
Dividend
0,10%
Quarterly dividend
0,50 ₹
Ex-dividend date
2026 ж. 08 мам.
P/E ratio
101,80
52-wk high
2 086,00 ₹
52-wk low
870,05 ₹
EPS
20,23 ₹
Shares outstanding
106,44 млн
No. of employees
7 мың
Open
2 027,35 ₹
High
2 086,00 ₹
Low
2 027,35 ₹
Mkt. cap
1,11 трлн
Avg. vol.
84,29 мың
Volume
103,13 м.
Dividend
0,10%
Quarterly dividend
0,50 ₹
Ex-dividend date
2026 ж. 08 мам.
P/E ratio
101,80
52-wk high
2 086,00 ₹
52-wk low
870,05 ₹
EPS
20,23 ₹
Shares outstanding
106,44 млн
No. of employees
7 мың
News stories
From web sources and news partners
The Economic Times
·
2 күн бұрын
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees7,06 мың
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitelauruslabs.com